Table 1. Demographic and clinical characteristics of participants.
| Subacute Group | Chronic Group | Delta Group | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Lesion side | Right (n = 65) | Left (n = 65) | p. value | Right (n = 32) | Left (n = 34) | p. value | Right (n = 24) | Left (n = 25) | p. value |
| Gender (M/F) | 43/22 | 45/18 | 0.447a | 26/6 | 26/8 | 0.635a | 17/7 | 21/4 | 0.269a |
| Age: Mean (SD) | 60.94 (9.92) | 60.17 (11.58) | 0.204c | 62.97 (9.76) | 60.13 (10.40) | 0.132c | 60.54 (9.97) | 58.16 (10.84) | 0.427b |
| Dominance (R/L/A) | 60/3/2 | 62/3/0 | 0.362a | 29/2/1 | 32/2/0 | 0.580a | 22/1/1 | 25/0/0 | 0.338a |
| Lesion type (I/H/I>H) | 47/16/2 | 47/17/1 | 0.834a | 20/9/3 | 21/13/0 | 0.158a | 16/6/2 | 13/12/0 | 0.117a |
| TAO months | 1.34 (0.64) | 1.44 (0.59) | 0.221c | 29.31 (14.33) | 28.40 (14.46) | 0.807c | 27.64 (15.15) | 27.48 (15.07) | 0.912c |
| Lesion volume: cc | 25.48 (36.35) | 20.12 (23.30) | 0.497c | 30.90 (41.88) | 23.78 (26.86) | 0.868c | 29.40 (42.26) | 22.42 (22.76) | 0.424c |
| FM A: X/30 (SD) | 16.92 (11.00) | 17.38 (9.79) | 0.884c | 20.84 (12.17) | 21.91 (8.30) | 0.449c | 2.38 (4.19) | 5.92 (7.64) | 0.106 c |
| FM B+C: X/24 (SD) | 12.83 (9.65) | 13.11 (9.05) | 0.973c | 15.91 (10.11) | 16.29 (8.20) | 0.687c | 1.71 (4.17) | 3.40 (6.73) | 0.291c |
| FM Total: X/66 (SD) | 36.55 (22.53) | 36.71 (21.19) | 0.985c | 44.31 (24.57) | 45.79 (17.85) | 0.492c | 4.04 (9.69) | 9.76 (14.91) | 0.186c |
| B&B*: Mean (SD) | 19.95 (20.19) | 21.13 (19.13) | 0.703c | 28.59 (22.76) | 30.45 (23.32) | 0.772c | 3.4 (12.87) | 8.88 (9.61) | 0.264b |
| FM Sensation: X/12(SD) | 8.77 (3.90) | 9.90 (3.31) | 0.129c | 8.93 (3.53) | 9.41 (3.97) | 0.394c | 1.46 (4.31) | 1.13 (2.10) | 0.686c |
| VFD (no/extinction/yes) | 56/6/3 | 59/3/3 | 0.583a | 26/5/1 | 33/1/0 | 0.109a | 20/3/1 | 24/1/0 | 0.310a |
Dominance R = Right, L = Left, A = Ambidextrous; Lesion type I = Ischemic, H = Hemorrhagic, I>H = Ischemic with hemorrhagic transformation; TAO = Time after stroke onset–mean (SD); FM = Fugl-Meyer, B&B = Box and Blocks; VFD—visual field defect
* Number of participants in the B&B test: in the subacute phase—n = 38 (right) and n = 48 (left), in the chronic phase—n = 29 (right) and n = 29 (left), in the delta–n = 10 (right) and n = 16 (left); Number of participants in the FM sensation test: in the subacute phase—n = 43 (right) and n = 41 (left), in the chronic phase–n = 28 (right) and n = 27 (left), in the delta–n = 10 (right) and n = 16 (left); for the Delta group—TAO, FM, B&B and sensation data are mean and SD values of the difference (delta) in scores from the subacute to the chronic phase, and values of Age and VFD are of the subacute phase. a = Chi-Square test, b = t test, c = Mann Whitney test.